Astria Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
ATXS
CUSIP
04635X102
Type
Equity
Class
COM
Num filings
109
Total reported value, excl. options
$622 M
Manager Report Date Value ($000) Shares Option Type